Brief: Atara Biotherapeutics Q2 EPS USD -0.32
12/08/2026 21:06
BRIEF-Atara Biotherapeutics Q2 EPS USD -0.32 Aug 12 (Reuters) - Atara Biotherapeutics Q2 operating income USD -4.72 million.
- Q2 net income USD -4.834 million
- Q2 revenue USD 630 thousand
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing